Different combination schedules of gemcitabine with endostar affect antitumor efficacy.
Peng XC, Qiu M, Wei M, Tan BX, Ge J, Zhao Y, Chen Y, Cheng K, Zhou Y, Wu Y, Gong FM, Li Q, Xu F, Bi F, Liu JY.
Peng XC, et al. Among authors: chen y.
Cancer Chemother Pharmacol. 2012 Jan;69(1):239-46. doi: 10.1007/s00280-011-1695-8. Epub 2011 Jun 26.
Cancer Chemother Pharmacol. 2012.
PMID: 21706279